Did a boy’s life-saving gene therapy cause his brain tumour?

This article highlights a critical concern in gene therapy, where a life-saving treatment may have inadvertently contributed to the development of a brain tumor in a young patient. It underscores the importance of rigorous safety evaluations in emerging biotech therapies, impacting both the industry and patient safety. As gene editing technologies advance, understanding and mitigating potential risks is essential for responsible innovation and public trust.

• Gene therapy can have unforeseen adverse effects.
• Rigorous safety assessments are crucial for biotech innovations.
• Monitoring long-term outcomes is vital for patient safety.